Drugs / AZD9742
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01275781 | Jan → Feb 2011 | — | AstraZeneca | Withdrawn | No outcome recorded |
| Phase 1 | NCT01154621 | Jun → Jul 2010 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT01124760 | May → Jul 2010 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT01114152 | Apr → Jul 2010 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT01064388 | Feb → Aug 2010 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT01030224 | Nov 2009 → Mar 2010 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD9742 | “Open Label Study, Assessing the Effect of Diltiazem or Ketoconazole on the Pharmacokinetics of AZD9742 in Healthy Volunteers” NCT01124760 ↗ |
| Route | Intravenous | “single IV infusion doses of AZD9742” NCT01030224 ↗ |